An Open-label, Randomized, Single Dose, Crossover Phase I Clinical Trial to Compare Pharmacokinetic Property of SYO-1126 and Glivec Film Coated Tab., 4T (400mg) in Healthy Male Volunteers

Trial Profile

An Open-label, Randomized, Single Dose, Crossover Phase I Clinical Trial to Compare Pharmacokinetic Property of SYO-1126 and Glivec Film Coated Tab., 4T (400mg) in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Jun 2012

At a glance

  • Drugs Imatinib (Primary)
  • Indications Haematological malignancies; Malignant melanoma; Myelodysplastic syndromes; Polycythaemia vera; Prostate cancer; Sarcoma
  • Focus Pharmacokinetics
  • Most Recent Events

    • 11 Jun 2012 Actual end date (April 2012) added as reported by ClinicalTrials.gov.
    • 11 Jun 2012 Actual initiation date (Mar 2012) added as reported by ClinicalTrials.gov.
    • 11 Jun 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top